{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:32:06Z","timestamp":1789205526071,"version":"build-2803163510"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","clineu-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.clineuro.2016.09.006","type":"journal-article","created":{"date-parts":[[2016,9,18]],"date-time":"2016-09-18T12:30:19Z","timestamp":1474201819000},"page":"125-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Prion diseases: New considerations"],"prefix":"10.1016","volume":"150","author":[{"given":"\u00c1d\u00e1m","family":"Annus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anett","family":"Cs\u00e1ti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"V\u00e9csei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2016.09.006_bib0005","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","article-title":"Prions","volume":"95","author":"Prusiner","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0010","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/01.WNL.0000160117.56690.B2","article-title":"Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada","volume":"64","author":"Ladogana","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2016.09.006_bib0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/15622970410029916","article-title":"Rationale for diagnosing human prion disease","volume":"5","author":"Kovacs","year":"2004","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.clineuro.2016.09.006_bib0020","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00439-005-0020-1","article-title":"Genetic prion disease: the EUROCJD experience","volume":"118","author":"Kovacs","year":"2005","journal-title":"Hum. Genet."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0025","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/bmb\/66.1.255","article-title":"Acquired prion disease: iatrogenic CJD, variant CJD, kuru","volume":"66","author":"Will","year":"2003","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0030","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1126\/science.6801762","article-title":"Novel proteinaceous infectious particles cause scrapie","volume":"216","author":"Prusiner","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.clineuro.2016.09.006_bib0035","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0092-8674(87)90150-4","article-title":"Scrapie prion protein contains a phosphatidylinositol glycolipid","volume":"51","author":"Stahl","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.clineuro.2016.09.006_bib0040","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0092-8674(90)90225-4","article-title":"Cellular isoform of the scrapie agent protein participates in lymphocyte activation","volume":"61","author":"Cashman","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.clineuro.2016.09.006_bib0045","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1044-7431(02)00014-3","article-title":"Prion protein as trans-interacting partner for neurons is involved in neurite outgrowth and neuronal survival","volume":"22","author":"Chen","year":"2003","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0050","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0169-328X(99)00334-4","article-title":"Cellular prion protein binds laminin and mediates neuritogenesis","volume":"76","author":"Graner","year":"2000","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0055","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1242\/jcs.03459","article-title":"Cellular prion protein interaction with vitronectin supports axonal growth and is compensated by integrins","volume":"120","author":"Hajj","year":"2007","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0060","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/j.1471-4159.2005.03469.x","article-title":"Recombinant prion protein induces rapid polarization and development of synapses in embryonic rat hippocampal neurons in vitro","volume":"95","author":"Kanaani","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0065","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1371\/journal.pbio.1000055","article-title":"Regulation of embryonic cell adhesion by the prion protein","volume":"7","author":"Malaga-Trillo","year":"2009","journal-title":"PLoS Biol."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0070","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1083\/jcb.200409127","article-title":"Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59 fyn and to enhance neurite outgrowth","volume":"169","author":"Santuccione","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0075","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1073\/pnas.0510577103","article-title":"Prion protein is expressed on long-term repopulating hematopoietic stem cells and is important for their self-renewal","volume":"103","author":"Zhang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0080","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/382180a0","article-title":"NMR structure of the mouse prion protein domain PrP(121\u2013231)","volume":"382","author":"Riek","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.clineuro.2016.09.006_bib0085","doi-asserted-by":"crossref","first-page":"10962","DOI":"10.1073\/pnas.90.23.10962","article-title":"Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins","volume":"90","author":"Pan","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0090","doi-asserted-by":"crossref","first-page":"975832","DOI":"10.1155\/2013\/975832","article-title":"From prion diseases to prion-like propagation mechanisms of neurodegenerative diseases","volume":"2013","author":"Acquatella-Tran Van Ba","year":"2013","journal-title":"Int J Cell Biol"},{"key":"10.1016\/j.clineuro.2016.09.006_bib0095","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrm2873","article-title":"Prion-like transmission of protein aggregates in neurodegenerative diseases","volume":"11","author":"Brundin","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0100","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2353\/ajpath.2008.070442","article-title":"Prion diseases: from protein to cell pathology","volume":"172","author":"Kovacs","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0105","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/jnr.10864","article-title":"Neuroprotective functions of prion protein","volume":"75","author":"Roucou","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0110","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/382779a0","article-title":"Transmission dynamics and epidemiology of BSE in British cattle","volume":"382","author":"Anderson","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.clineuro.2016.09.006_bib0115","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jns.2007.01.033","article-title":"Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders","volume":"257","author":"Sas","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0120","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.2174\/092986712800167365","article-title":"Mitochondrial disturbances, tryptophan metabolites and neurodegeneration: medicinal chemistry aspects","volume":"19","author":"Szalardy","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0125","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1582-4934.2010.01237.x","article-title":"Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines","volume":"15","author":"Zadori","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0130","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00702-009-0263-4","article-title":"Kynurenines in chronic neurodegenerative disorders: future therapeutic strategies","volume":"116","author":"Zadori","year":"2009","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0135","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nrd3793","article-title":"Kynurenines in the CNS: recent advances and new questions","volume":"12","author":"Vecsei","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0140","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrn2477","article-title":"Research in motion: the enigma of Parkinson\u2019s disease pathology spread","volume":"9","author":"Brundin","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0145","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nm1747","article-title":"Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease","volume":"14","author":"Kordower","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0150","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/ncb1901","article-title":"Transmission and spreading of tauopathy in transgenic mouse brain","volume":"11","author":"Clavaguera","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0155","doi-asserted-by":"crossref","first-page":"41452","DOI":"10.1074\/jbc.M303354200","article-title":"Mutant huntingtin promotes the fibrillogenesis of wild-type huntingtin: a potential mechanism for loss of huntingtin function in Huntington's disease","volume":"278","author":"Busch","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0160","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1073\/pnas.1017275108","article-title":"Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells","volume":"108","author":"Munch","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0165","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/3311","article-title":"Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease","volume":"4","author":"Conway","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0170","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.1073\/pnas.0809232106","article-title":"Interplay of alpha-synuclein binding and conformational switching probed by single-molecule fluorescence","volume":"106","author":"Ferreon","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0175","doi-asserted-by":"crossref","first-page":"20051","DOI":"10.1073\/pnas.0908005106","article-title":"Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells","volume":"106","author":"Luk","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0180","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.clineuro.2016.09.006_bib0185","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson\u2019s disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0190","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/mds.23012","article-title":"Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson\u2019s disease","volume":"25","author":"Li","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0195","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s40478-014-0088-8","article-title":"Pathological alpha-synuclein propagates through neural networks","volume":"2","author":"Masuda-Suzukake","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0200","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1111\/ejn.12229","article-title":"Spreading of tau pathology in Alzheimer's disease by cell-to-cell transmission","volume":"37","author":"Mohamed","year":"2013","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0205","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/nan.12197","article-title":"Invited review: prion-like transmission and spreading of tau pathology","volume":"41","author":"Clavaguera","year":"2015","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0210","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1523\/JNEUROSCI.20-10-03606.2000","article-title":"Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice","volume":"20","author":"Kane","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0215","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1126\/science.1131864","article-title":"Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host","volume":"313","author":"Meyer-Luehmann","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.clineuro.2016.09.006_bib0220","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nature07761","article-title":"Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers","volume":"457","author":"Lauren","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.clineuro.2016.09.006_bib0225","doi-asserted-by":"crossref","first-page":"8935","DOI":"10.1074\/jbc.M112.400358","article-title":"Prion protein-mediated toxicity of amyloid-beta oligomers requires lipid rafts and the transmembrane LRP1","volume":"288","author":"Rushworth","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0230","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1523\/JNEUROSCI.4152-10.2011","article-title":"Amyloid-beta\/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer\u2019s disease","volume":"31","author":"Roberson","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0235","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4161\/pri.22212","article-title":"Amyloid-beta induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease","volume":"7","author":"Um","year":"2013","journal-title":"Prion"},{"key":"10.1016\/j.clineuro.2016.09.006_bib0240","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1073\/pnas.0911829107","article-title":"Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein","volume":"107","author":"Balducci","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0245","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/emmm.201000082","article-title":"Prion protein and abeta-related synaptic toxicity impairment","volume":"2","author":"Calella","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0250","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1038\/nature09217","article-title":"The prion protein as a receptor for amyloid-beta","volume":"466","author":"Kessels","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.clineuro.2016.09.006_bib0255","doi-asserted-by":"crossref","first-page":"33489","DOI":"10.1074\/jbc.M111.278556","article-title":"Prion protein interacts with BACE1 protein and differentially regulates its activity toward wild type and Swedish mutant amyloid precursor protein","volume":"286","author":"Griffiths","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0260","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1083\/jcb.200711002","article-title":"Prion protein attenuates excitotoxicity by inhibiting NMDA receptors","volume":"181","author":"Khosravani","year":"2008","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0265","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4161\/pri.22511","article-title":"Alpha-cleavage of cellular prion protein","volume":"6","author":"Liang","year":"2012","journal-title":"Prion"},{"key":"10.1016\/j.clineuro.2016.09.006_bib0270","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1074\/jbc.M113.502351","article-title":"A new paradigm for enzymatic control of alpha-cleavage and beta-cleavage of the prion protein","volume":"289","author":"McDonald","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0275","doi-asserted-by":"crossref","first-page":"7857","DOI":"10.1074\/jbc.M112.423954","article-title":"An N-terminal fragment of the prion protein binds to amyloid-beta oligomers and inhibits their neurotoxicity in vivo","volume":"288","author":"Fluharty","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0280","doi-asserted-by":"crossref","first-page":"35973","DOI":"10.1074\/jbc.M109.051086","article-title":"The alpha-secretase-derived N-terminal product of cellular prion, N1, displays neuroprotective function in vitro and in vivo","volume":"284","author":"Guillot-Sestier","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0285","doi-asserted-by":"crossref","first-page":"44234","DOI":"10.1074\/jbc.M111.286195","article-title":"A naturally occurring C-terminal fragment of the prion protein (PrP) delays disease and acts as a dominant-negative inhibitor of PrPSc formation","volume":"286","author":"Westergard","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0290","doi-asserted-by":"crossref","first-page":"16398","DOI":"10.1073\/pnas.1102645108","article-title":"Intermolecular transmission of superoxide dismutase 1 misfolding in living cells","volume":"108","author":"Grad","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0295","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jmb.2011.12.061","article-title":"Propagation of the prion phenomenon: beyond the seeding principle","volume":"421","author":"Munch","year":"2012","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0300","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.abb.2004.08.009","article-title":"Expression of a familial amyotrophic lateral sclerosis-associated mutant human superoxide dismutase in yeast leads to decreased mitochondrial electron transport","volume":"431","author":"Gunther","year":"2004","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0305","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3390\/ijms10030976","article-title":"Molecular pathology of human prion diseases","volume":"10","author":"Kovacs","year":"2009","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0310","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","article-title":"Staging of Alzheimer\u2019s disease-related neurofibrillary changes","volume":"16","author":"Braak","year":"1995","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.clineuro.2016.09.006_bib0315","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0320","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1093\/brain\/awp191","article-title":"Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease","volume":"132","author":"Zerr","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.clineuro.2016.09.006_bib0325","series-title":"WHO Manual for Surveillance of Human Transmissible Spongiform Encephalopathies Including Variant Creutzfeldt-Jakob Disease","author":"WHO","year":"2003"},{"key":"10.1016\/j.clineuro.2016.09.006_bib0330","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1212\/01.wnl.0000196440.00297.67","article-title":"First symptom in sporadic Creutzfeldt-Jakob disease","volume":"66","author":"Rabinovici","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2016.09.006_bib0335","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1600-0404.1998.tb00617.x","article-title":"Clinical changes and EEG patterns preceding the onset of periodic sharp wave complexes in Creutzfeldt-Jakob disease","volume":"97","author":"Hansen","year":"1998","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0340","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/ana.20261","article-title":"Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease","volume":"56","author":"Steinhoff","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0345","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1212\/WNL.0b013e3181a96e5d","article-title":"MRI lesion profiles in sporadic Creutzfeldt-Jakob disease","volume":"72","author":"Meissner","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2016.09.006_bib0350","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1212\/WNL.0b013e31821a4439","article-title":"Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias","volume":"76","author":"Vitali","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2016.09.006_bib0355","first-page":"361","article-title":"Human transmissible spongiform encephalopathies","volume":"73","author":"WHO","year":"1998","journal-title":"Wkly. Epidemiol. Rec."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0360","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1212\/WNL.0b013e318263565f","article-title":"A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease","volume":"79","author":"Hamlin","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2016.09.006_bib0365","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0140-6736(99)01342-2","article-title":"Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease","volume":"353","author":"Alperovitch","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.clineuro.2016.09.006_bib0370","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4161\/pri.5.3.16893","article-title":"Real-time quaking-induced conversion: a highly sensitive assay for prion detection","volume":"5","author":"Atarashi","year":"2011","journal-title":"Prion"},{"key":"10.1016\/j.clineuro.2016.09.006_bib0375","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ana.23589","article-title":"Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease","volume":"72","author":"McGuire","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0380","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02451-14","article-title":"Rapid and sensitive RT-QuIC detection of human Creutzfeldt-Jakob disease using cerebrospinal fluid","volume":"6","author":"Orru","year":"2015","journal-title":"MBio"},{"key":"10.1016\/j.clineuro.2016.09.006_bib0385","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1056\/NEJMoa1315200","article-title":"A test for Creutzfeldt-Jakob disease using nasal brushings","volume":"371","author":"Orru","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0390","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1056\/NEJMoa1404401","article-title":"Prions in the urine of patients with variant Creutzfeldt-Jakob disease","volume":"371","author":"Moda","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0395","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1098\/rstb.2008.0091","article-title":"Central and peripheral pathology of kuru: pathological analysis of a recent case and comparison with other forms of human prion disease","volume":"363","author":"Brandner","year":"2008","journal-title":"Philos. Trans. R Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0400","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0002-9440(10)63105-7","article-title":"Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study","volume":"164","author":"Head","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0405","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0140-6736(01)05403-4","article-title":"Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay","volume":"358","author":"Wadsworth","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.clineuro.2016.09.006_bib0410","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1128\/JVI.02852-12","article-title":"Aerosol transmission of chronic wasting disease in white-tailed deer","volume":"87","author":"Denkers","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0415","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1099\/vir.0.017335-0","article-title":"Aerosol and nasal transmission of chronic wasting disease in cervidized mice","volume":"91","author":"Denkers","year":"2010","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0420","doi-asserted-by":"crossref","first-page":"e1001257","DOI":"10.1371\/journal.ppat.1001257","article-title":"Aerosols transmit prions to immunocompetent and immunodeficient mice","volume":"7","author":"Haybaeck","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0425","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1128\/JVI.02649-06","article-title":"The nasal cavity is a route for prion infection in hamsters","volume":"81","author":"Kincaid","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0430","doi-asserted-by":"crossref","first-page":"12731","DOI":"10.1128\/JVI.01930-12","article-title":"Rapid transepithelial transport of prions following inhalation","volume":"86","author":"Kincaid","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0435","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3201\/eid1806.120116","article-title":"Iatrogenic Creutzfeldt-Jakob disease, final assessment","volume":"18","author":"Brown","year":"2012","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0440","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/BF03401958","article-title":"Transmission of scrapie by steel-surface-bound prions","volume":"7","author":"Flechsig","year":"2001","journal-title":"Mol. Med."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0445","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jhin.2014.06.002","article-title":"Managing the risk of iatrogenic transmission of Creutzfeldt-Jakob disease in the UK","volume":"88","author":"Hall","year":"2014","journal-title":"J. Hosp. Infect."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0450","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.3171\/2016.5.FOCUS15126","article-title":"Human prion diseases: surgical lessons learned from iatrogenic prion transmission","volume":"41","author":"Bonda","year":"2016","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.clineuro.2016.09.006_bib0455","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1212\/01.wnl.0000231528.65069.3f","article-title":"Iatrogenic Creutzfeldt-Jakob disease: the waning of an era","volume":"67","author":"Brown","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2016.09.006_bib0460","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/ICO.0b013e31816a628d","article-title":"Creutzfeldt-Jakob disease in recipients of corneal transplants","volume":"27","author":"Maddox","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.clineuro.2016.09.006_bib0465","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/nm0901-976","article-title":"Transepithelial prion transport by M cells","volume":"7","author":"Heppner","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0470","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1099\/0022-1317-80-11-3035","article-title":"Pathogenesis of the oral route of infection of mice with scrapie and bovine spongiform encephalopathy agents","volume":"80","author":"Maignien","year":"1999","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0475","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0304-3940(99)00934-9","article-title":"Early accumulation of pathological PrP in the enteric nervous system and gut-associated lymphoid tissue of hamsters orally infected with scrapie","volume":"278","author":"Beekes","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0480","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1099\/0022-1317-79-3-601","article-title":"Cerebral targeting indicates vagal spread of infection in hamsters fed with scrapie","volume":"79","author":"Beekes","year":"1998","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0485","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1155\/2001\/40871","article-title":"Close vicinity of PrP expressing cells (FDC) with noradrenergic fibers in healthy sheep spleen","volume":"8","author":"Bencsik","year":"2001","journal-title":"Dev. Immunol."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0490","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.expneurol.2009.04.025","article-title":"Transport of prion protein across the blood-brain barrier","volume":"218","author":"Banks","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0495","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1099\/0022-1317-77-7-1595","article-title":"Scrapie infection can be established readily through skin scarification in immunocompetent but not immunodeficient mice","volume":"77","author":"Taylor","year":"1996","journal-title":"Gen. Virol."},{"key":"10.1016\/j.clineuro.2016.09.006_bib0500","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jocn.2013.01.007","article-title":"Iatrogenic Creutzfeldt-Jakob disease via surgical instruments","volume":"20","author":"Thomas","year":"2013","journal-title":"J. Clin. Neurosci."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846716303377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846716303377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T14:09:26Z","timestamp":1568383766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846716303377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":100,"alternative-id":["S0303846716303377"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2016.09.006","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prion diseases: New considerations","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2016.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}